1-20 of 145
Betül Oran
Close
Sort by
Journal Articles

Phase 1/2 Trial to Jointly Optimize Dose and Administration Schedule of Evomela in Newly Diagnosed Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation

Qaiser Bashir, Peter Thall, Dawen Sui, Jitesh Kawedia, Cristina Knape, Ruby Delgado, Jandi L Schindler, Uday R. Popat, Partow Kebriaei, Chitra Hosing, Issa F. Khouri, Yago Nieto, Betul Oran, Samer A. Srour, Neeraj Y. Saini, Amanda L. Olson, Sairah Ahmed, Gheath Alatrash, Gabriela Rondon, Hans C. Lee, Sheeba K. Thomas, Elisabet E. Manasanch, Krina K. Patel, Robert Z. Orlowski, Richard E. Champlin, Elizabeth J. Shpall, Muzaffar H. Qazilbash
Journal: Blood
Blood (2023) 142 (Supplement 1): 4972.
https://doi.org/10.1182/blood-2023-189844
Published: 2023
Journal Articles

Incidence and Risk Factors of Veno-Occlusive Disease Are Different in Younger Versus Older Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Curtis Marcoux, Rima M. Saliba, Whitney Wallis, Sajad Khazal, Dristhi Ragoonanan, Gabriela Rondon, Priti Tewari, Uday R. Popat, Betul Oran, Amanda L. Olson, Qaiser Bashir, Muzaffar H. Qazilbash, Amin Alousi, Chitra Hosing, Yago Nieto, Gheath Alatrash, David Marin, Katayoun Rezvani, Issa F. Khouri, Samer A. Srour, Richard E. Champlin, Elizabeth J. Shpall, Partow Kebriaei
Journal: Blood
Blood (2023) 142 (Supplement 1): 4920.
https://doi.org/10.1182/blood-2023-185025
Published: 2023
Journal Articles

Patient Characteristics and Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Muzaffar H. Qazilbash, Hina N. Khan, Denái R. Milton, Oren Pasvolsky, Mark R. Tanner, Uday R. Popat, Partow Kebriaei, Chitra Hosing, Issa F. Khouri, Katayoun Rezvani, Yago Nieto, Betul Oran, Samer A. Srour, Neeraj Y. Saini, Amanda L. Olson, Sairah Ahmed, Gheath Alatrash, Gabriela Rondon, Marina Y. Konopleva, Richard E. Champlin, Elizabeth J. Shpall, Qaiser Bashir, Naveen Pemmaraju
Journal: Blood
Blood (2023) 142 (Supplement 1): 4988.
https://doi.org/10.1182/blood-2023-181031
Published: 2023
Journal Articles

Clinical and Prognostic Implications of WT1 Mutations in De Novo and Relapsed Acute Myeloid Leukemia

Himachandana Atluri, Jeremy DiGennaro, Keyur P. Patel, Mark Routbort, Betul Oran, Ghayas C. Issa, Nicholas J. Short, Naval Daver, Tapan M. Kadia, Farhad Ravandi, Uday R. Popat, Richard E. Champlin, Elizabeth J. Shpall, Sherry Pierce, Rashmi Kanagal-Shamanna, Chi Young Ok, Guilin Tang, Sa A. Wang, Raja Luthra, Audrey Lasry, Bettina Nadorp, Antonia Chroni, Ann-Kathrin Eisfeld, Iannis Aifantis, Najla H Al Ali, David A Sallman, Jeffrey Lancet, Onyee Chan, Eric Padron, Zhuoer Xie, L. Jeffrey Medeiros, Courtney D. DiNardo, Rami S. Komrokji, Sanam Loghavi
Journal: Blood
Blood (2023) 142 (Supplement 1): 959.
https://doi.org/10.1182/blood-2023-188319
Published: 2023
Journal Articles

Allogeneic Transplant for CLL Richter's Transformation: Single Center Retrospective Analysis

Alejandro Marinos Velarde, Rima M. Saliba, Celina Ledesma, Elizabeth J. Shpall, Muzaffar H. Qazilbash, Uday R. Popat, Qaiser Bashir, Yago Nieto, David Marin, Betul Oran, Amanda L. Olson, Samer A. Srour, Amin Alousi, Jeremy Ramdial, Partow Kebriaei, Alessandra Ferrajoli, William G. Wierda, Richard E. Champlin, Chitra Hosing
Journal: Blood
Blood (2023) 142 (Supplement 1): 7086.
https://doi.org/10.1182/blood-2023-173194
Published: 2023
Journal Articles

Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages

Simone Feurstein, Amy M. Trottier, Noel Estrada-Merly, Matthew Pozsgai, Kelsey McNeely, Michael W. Drazer, Brian Ruhle, Katharine Sadera, Ashwin L. Koppayi, Bart L. Scott, Betul Oran, Taiga Nishihori, Vaibhav Agrawal, Ayman Saad, R. Coleman Lindsley, Ryotaro Nakamura, Soyoung Kim, Zhenhuan Hu, Ronald Sobecks, Stephen Spellman, Wael Saber, Lucy A. Godley
Journal: Blood
Blood (2022) 140 (24): 2533–2548.
https://doi.org/10.1182/blood.2022015790
Published: 2022
Includes: Supplemental data
Journal Articles

Transplant Outcomes for TP53 AML and MDS in a Contemporary Era

Gonca Ozcan, Uday R Popat, Partow Kebriaei, Amin M Alousi, Gheath Alatrash, Qaiser Bashir, Rohtesh S. Mehta, Jeremy L. Ramdial, Gabriela Rondon, Elizabeth J Shpall, Richard E Champlin, Betul Oran
Journal: Blood
Blood (2022) 140 (Supplement 1): 10620–10621.
https://doi.org/10.1182/blood-2022-157039
Published: 2022
Journal Articles

HLA B-Leader Mismatch Is Associated with Poor Outcomes in NIMA/NIPA Mismatched Haploidentical Sibling Donor HCT

Rohtesh S. Mehta, Rima M. Saliba, Amin M. Alousi, Gheath Alatrash, Qaiser Bashir, Chitra Hosing, Partow Kebriaei, Issa F. Khouri, Yago Nieto, Betul Oran, Uday R. Popat, Muzaffar H. Qazilbash, Jeremy L. Ramdial, Gabriela Rondon, Samer A. Srour, Katy Rezvani, Richard E. Champlin, Elizabeth J. Shpall, Kai Cao
Journal: Blood
Blood (2022) 140 (Supplement 1): 4880–4881.
https://doi.org/10.1182/blood-2022-158689
Published: 2022
Journal Articles

Efficacy of Azacitidine Post-Transplant Maintenance for FLT3-Negative Acute Myeloid Leukemia and Myelodysplastic Syndrome

Oren Pasvolsky, Rima M. Saliba, Uday R Popat, Amin M Alousi, Rohtesh S. Mehta, Jason Yeh, Gheath Alatrash, Adeel Masood, Jeremy L. Ramdial, Gabriela Rondon, Partow Kebriaei, Richard E Champlin, Elizabeth J Shpall, Betul Oran
Journal: Blood
Blood (2022) 140 (Supplement 1): 10550–10551.
https://doi.org/10.1182/blood-2022-159336
Published: 2022
Journal Articles

Early Results of MT-401 (Zedenoleucel) in Post-Transplant MRD + aml Patients

Mythili Koneru, Shukaib Arslan, Margarida Magalhaes Magalhaes-Silverman, Hongtao Liu, Nelli Bejanyan, Antonio Di Stasi, Robin McCallum, Silvia Quintero, Gerald Garrett, Karrie Wang, Eric Smith, Tara Shahim, Lina Hoang, Jeannette Crisostomo, Anna Wilga-Savitski, Jennifer Pickering, Laura Angelo, Anastasiya Smith, Juan F. Vera, Betul Oran, Jingmei Hsu
Journal: Blood
Blood (2022) 140 (Supplement 1): 12718–12719.
https://doi.org/10.1182/blood-2022-155602
Published: 2022
Journal Articles

Mother Vs Father Haploidentical Donor for T Cell-Replete HCT with Ptcy Prophylaxis

Rohtesh S. Mehta, Rima M. Saliba, Amin M Alousi, Gheath Alatrash, Qaiser Bashir, Partow Kebriaei, Issa F. Khouri, Yago Nieto, Betul Oran, Uday R Popat, Muzaffar H Qazilbash, Jeremy L. Ramdial, Gabriela Rondon, Samer A Srour, Katy Rezvani, Richard E Champlin, Elizabeth J Shpall, Kai Cao
Journal: Blood
Blood (2022) 140 (Supplement 1): 10530–10531.
https://doi.org/10.1182/blood-2022-166472
Published: 2022
Journal Articles

A Phase II Clinical Trial of "Off-the-Shelf" NK Cells with Allogeneic Stem Cell Transplantation to Decrease Disease Relapse in Patients with High-Risk Myeloid Malignancies

Jeremy L. Ramdial, Lorlyn Clemente-Sevilla, Doris Soebbing, Bouthaina S. Dabaja, Peter F Thall, Gheath Alatrash, Amin M Alousi, Rohtesh S. Mehta, Uday R Popat, Partow Kebriaei, Betul Oran, Katy Rezvani, Elizabeth J Shpall, Richard E Champlin
Journal: Blood
Blood (2022) 140 (Supplement 1): 7484–7485.
https://doi.org/10.1182/blood-2022-170663
Published: 2022
Journal Articles

First in Human Study of Anti-Viral Veto Cells Enabling Successful Engraftment without Severe Gvhd in Non-Myeloablative T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation (HSCT)

Richard E Champlin, Esther Bachar Lustig, Qaiser Bashir, Betul Oran, Steven M. Kornblau, Chitra Hosing, Amin M Alousi, Uday R Popat, Jessica M McCarty, Peter F Thall, Bouthaina S. Dabaja, Wei-Hsin Liu, Giang Dang, Karla Castro, Alejandro Ramirez, Michael Spiotto, Susan Wu, Penny Fang, Indreshpal Kaur, Katy Rezvani, Elizabeth J Shpall, Yair Reisner
Journal: Blood
Blood (2022) 140 (Supplement 1): 2120–2122.
https://doi.org/10.1182/blood-2022-159183
Published: 2022
Journal Articles

Son Vs Daughter Haploidentical Donor for T Cell-Replete HCT with Ptcy Prophylaxis

Rohtesh S. Mehta, Rima M. Saliba, Amin M Alousi, Gheath Alatrash, Qaiser Bashir, Chitra Hosing, Partow Kebriaei, Issa F. Khouri, Yago Nieto, Betul Oran, Uday R Popat, Muzaffar H Qazilbash, Jeremy L. Ramdial, Gabriela Rondon, Samer A Srour, Katy Rezvani, Richard E Champlin, Elizabeth J Shpall, Kai Cao
Journal: Blood
Blood (2022) 140 (Supplement 1): 7649–7650.
https://doi.org/10.1182/blood-2022-166381
Published: 2022
Journal Articles

Phase II Trial of Venetoclax (Ven) in Combination with Azacitidine (AZA) As Maintenance Therapy for High-Risk Acute Leukemia Following Allogeneic Stem Cell Transplantation (SCT)

Betul Oran, Richard E Champlin, Peter F Thall, Jessica M McCarty, Wen Zhang, David Marin, Rohtesh S. Mehta, Amin M Alousi, Gheath Alatrash, Uday R Popat, Hagop Kantarjian, Qaiser Bashir, Elizabeth J Shpall, Marina Konopleva
Journal: Blood
Blood (2022) 140 (Supplement 1): 10561–10562.
https://doi.org/10.1182/blood-2022-159312
Published: 2022
Journal Articles

Long-Term Outcomes of Acute Myeloid Leukemia Following Allogeneic Stem-Cell Transplantation after Decitabine and Venetoclax: Subgroup Analysis of a Phase II Trial

Abhishek Maiti, Courtney D. DiNardo, Maro Ohanian, Naveen Pemmaraju, Naval Daver, Gautam Borthakur, Farhad Ravandi, Ghayas C. Issa, Guillermo Garcia-Manero, Nitin Jain, Tapan M. Kadia, Lucia Masarova, William G. Wierda, Musa Yilmaz, Yesid Alvarado, Elias Jabbour, Nicholas Short, Koichi Takahashi, Sanam Loghavi, Keyur P. Patel, Kathryn Montalbano, Sherry A. Pierce, Carol A. Bivins, Rohtesh S. Mehta, Gheath Alatrash, Uday R Popat, Partow Kebriaei, Betul Oran, Elizabeth J Shpall, Richard E Champlin, Hagop Kantarjian, Marina Konopleva
Journal: Blood
Blood (2022) 140 (Supplement 1): 7725–7728.
https://doi.org/10.1182/blood-2022-169896
Published: 2022
Journal Articles

Prognostic Significance of Measurable Residual Disease for Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Stem Cell Transplant in Second Complete Remission and Beyond

Oren Pasvolsky, Rima M. Saliba, Celina Ledesma, Uday R Popat, Amin M Alousi, Amanda L. Olson, Betul Oran, Chitra Hosing, Qaiser Bashir, Muzaffar H Qazilbash, Nicholas Short, Farhad Ravandi, Richard E Champlin, Elizabeth J Shpall, Partow Kebriaei
Journal: Blood
Blood (2022) 140 (Supplement 1): 7695–7696.
https://doi.org/10.1182/blood-2022-155916
Published: 2022
Journal Articles

Efficacy and Safety of Gilteritinib Vs. Sorafenib As Post-Transplant Maintenance in Patients with FLT3-ITD Acute Myeloid Leukemia

Jason Yeh, Rima M. Saliba, Christopher Wang, Zhou Fang, Bradley Figgins, Sairah Ahmed, Musa Yilmaz, Naval Daver, Rohtesh S. Mehta, Gheath Alatrash, David Marin, Uday R Popat, Richard E Champlin, Elizabeth J Shpall, Betul Oran
Journal: Blood
Blood (2022) 140 (Supplement 1): 7686–7688.
https://doi.org/10.1182/blood-2022-165780
Published: 2022
Journal Articles

Blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia

Clinical Trials & Observations
Mahmoud R. Gaballa, Pinaki Banerjee, Denái R. Milton, Xianli Jiang, Christina Ganesh, Sajad Khazal, Vandana Nandivada, Sanjida Islam, Mecit Kaplan, May Daher, Rafet Basar, Amin Alousi, Rohtesh Mehta, Gheath Alatrash, Issa Khouri, Betul Oran, David Marin, Uday Popat, Amanda Olson, Priti Tewari, Nitin Jain, Elias Jabbour, Farhad Ravandi, Hagop Kantarjian, Ken Chen, Richard Champlin, Elizabeth Shpall, Katayoun Rezvani, Partow Kebriaei
Journal: Blood
Blood (2022) 139 (12): 1908–1919.
https://doi.org/10.1182/blood.2021013290
Published: 2022
Includes: Supplemental data
Journal Articles

Myeloablative Fractionated Busulfan Conditioning Regimen with Sorafenib in Patients with AML: Results of Phase I Clinical Trial

Uday R. Popat, Roland Bassett, Peter F. Thall, Amin M. Alousi, Gheath Alatrash, Qaiser Bashir, Chitra Hosing, Jin S. Im, Partow Kebriaei, David Marin, Yago Nieto, Amanda L. Olson, Betul Oran, Jeremy L. Ramdial, Neeraj Saini, Samer A. Srour, Benigno C. Valdez, Katayoun Rezvani, Muzaffar H. Qazilbash, Naval Daver, Farhad Ravandi, Elizabeth J. Shpall, Richard E. Champlin, Borje S. Andersson, Rohtesh S. Mehta
Journal: Blood
Blood (2021) 138 (Supplement 1): 556.
https://doi.org/10.1182/blood-2021-152450
Published: 2021